Results 131 to 140 of about 43,675 (258)
The Role of EZH2 ın Malıgnant Pleural Mesothelıoma and Beyond: Current Practıce and Future Perspectıves. [PDF]
Kucukoner M +6 more
europepmc +1 more source
Myelodysplastic Syndromes: 2026 Update on Diagnosis, Risk‐Stratification and Management
ABSTRACT Disease Overview The myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid disorders characterized by peripheral blood cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and in individuals with prior exposure to cytotoxic therapy.
Guillermo Garcia‐Manero
wiley +1 more source
EZH2 enhances PCV2 replication through inhibition of MMP1 and MMP12 transcription activity. [PDF]
Shan Y +8 more
europepmc +1 more source
Celebration of the 13th ICCNS meeting joint to the 1st ARBIOCOM Conference held on the site of Nice in December 2025. Abstract The 13th International Workshop on the CCN Family of Genes, held in Nice as part of the inaugural ARBIOCOM World Conference, brought together investigators with diverse research backgrounds, disciplines, and expertise. Building
Bernard Perbal +3 more
wiley +1 more source
Ezh2 Control of Bivalent Genes Fine-Tunes Developmental Competence During Retinogenesis. [PDF]
Davis E, Khan A, Aldiri I.
europepmc +1 more source
Proposed gut‐vascular framework linking microbial ecology to atherosclerotic disease. Diet and related exposures shape dysbiosis or microbial resilience; resulting changes in SCFAs, TMAO, bile acids, and LPS may modulate endothelial function, immune activation, and platelet activity, contributing to atherosclerosis, ACS, and PAD.
Amr Ali Mohamed Abdelgawwad El‐Sehrawy +7 more
wiley +1 more source
DUAL INHIBITION OF EZH2 AND HDAC IS SYNERGISTIC IN EZH2 DYSREGULATED LYMPHOMAS [PDF]
J.K. Lue +5 more
openaire +1 more source
EZH2 Regulates the Pluripotency of Mouse Embryonic Stem Cells by Modulating <i>Nanog</i> Expression Under PKC Inhibition. [PDF]
Wu F +7 more
europepmc +1 more source
ABSTRACT BCL6 is a master transcriptional regulator of germinal center (GC) B cells. BCL6 is frequently translocated at the major translocation cluster (MTC) within intron 1 of the BCL6 locus, a hotspot commonly rearranged in diffuse large B cell lymphomas (DLBCLs).
Santosh Kumar Gothwal +4 more
wiley +1 more source

